Screen for hepatitis B virus in all cancer patients starting systemic treatment. Find out more about hepatitis B virus screening and management.

Drug Formulary

About the Drug Formulary Email Drug Formulary Team

What’s New in the Drug Formulary

All new and recently updated drug and regimen monographs, patient information sheets, as well as safety and advice documents are available here.

Regimen

DURV(MNT)

Published Date: 30 Jun 2025

Cancer Type:

Gynecologic,

Endometrial

Show More Show more tags

, Show Less Show fewer tags

Intent: Adjuvant, Curative, Palliative

Revision Summary: Regimen Monograph: new ST-QBP regimen

Jun 2025

Regimen

BELZ

Published Date: 24 Jun 2025

Cancer Type:

Endocrine,

Pancreatic Neuroendocrine,

Genitourinary,

Renal cell / Kidney

Show More Show more tags

, Show Less Show fewer tags

Intent: Curative, Palliative

Revision Summary: Regimen Monograph: Expanded into full regimen monograph

Jun 2025

Regimen

PEMB

Published Date: 20 Jun 2025

Cancer Type:

Breast,

Central Nervous System,

Endocrine,

Adrenal,

Neuroendocrine,

Pancreatic Neuroendocrine,

Parathyroid,

Thymoma,

Thyroid,

Gastrointestinal,

Anus,

Colorectal,

Esophagus,

Gastric / Stomach,

Gastrointestinal Stromal Tumours,

Hepatobiliary / Liver / Bile Duct,

Mesothelioma (Peritoneal),

Neuroendocrine (GI),

Pancreas,

Rectal,

Small bowel and appendix,

Genitourinary,

Bladder / Urothelial,

Penile,

Prostate,

Renal cell / Kidney,

Testis,

Gynecologic,

Cervix,

Endometrial,

Germ Cell,

Gestational Trophoblastic Disease,

Ovary,

Uterine Sarcoma,

Vagina,

Vulva,

Head and Neck,

Larynx,

Nasopharynx,

Oral,

Paranasal Sinus,

Pharynx,

Salivary Gland,

Squamous Cell,

Kaposi's Sarcoma,

Lung,

Mesothelioma (Pleural),

Neuroendocrine (Lung),

Non-Small Cell,

Small Cell,

Mesothelioma,

Ocular / Eye,

Sarcoma,

Desmoid Tumour,

Ewing's,

Ewing's and Soft Tissue,

GIST,

Giant Cell Tumour,

Kaposi's Sarcoma,

Osteogenic / Bone,

Soft Tissue,

Uterine,

Wilm's Tumour,

Skin,

Basal Cell,

Melanoma,

Merkel Cell,

Squamous Cell,

Unknown Primary

Show More Show more tags

, Show Less Show fewer tags

Intent: Palliative

Revision Summary: Regimen Monograph: new ST-QBP regimen

Jun 2025

Regimen

PEMB

Published Date: 20 Jun 2025

Cancer Type:

Lung,

Non-Small Cell

Show More Show more tags

, Show Less Show fewer tags

Intent: Adjuvant

Revision Summary: Regimen Monograph: Updated Rationale/Uses, Drug regimen, and Cycle frequency sections; Added NDFP form

Jun 2025

Regimen

AVD+BREN

Published Date: 20 Jun 2025

Cancer Type:

Hematologic,

Lymphoma - Hodgkin

Show More Show more tags

, Show Less Show fewer tags

Intent: Curative

Revision Summary: Regimen Monograph: Updated Rationale/Uses, Supplementary Public Funding, and Premedication/Supportive Measure sections

Jun 2025

Drug

pembrolizumab

Cancer Type:

Skin,

Melanoma

Show More Show more tags

, Show Less Show fewer tags

Intent: Palliative

Revision Summary: Regimen Monograph: Updated Pregnancy/Lactation section

Jun 2025

What’s New in the Drug Formulary

DURV(MNT)

BELZ

PEMB

PEMB

AVD+BREN

pembrolizumab

brentuximab vedotin

MIDO

DABRTRAM

DABRTRAM

DABRTRAM

TRAM

Pages